Diagnostic Importance of Relative Lymphopenia as a Marker of Swine Influenza (H1N1) in Adults
To the Editor-Unlike severe influenza A, which has characteristic findings, mild or moderate influenza A is clinically indistinguishable from influenza-like illness [1, 2] . Early in the swine influenza (H1N1) pandemic (April and May 2009), our emergency department was inundated with 856 patient requests for rapid influenza A testing and/or evaluation. The H1N1 pandemic began at the end of the annual human influenza A season, and other respiratory viruses that cause influenza-like illness were present in the community as well. Although the rapid flu test (Quick-S Influ A/B kit; Denka Seiken) has ∼20% false negative results for influenza A, it is used in our emergency department because it is rapid and inexpensive [3, 4] . In April and May, because the local health department was overwhelmed with requests for H1N1 testing, reverse transcription polymerase chain reaction (RT-PCR) testing was performed if the rapid influenza A test was positive and/or the patient reported recent travel to Mexico or close contact with New York City epicenter cases.
Previously, relative lymphopenia has been found to be an early and reliable laboratory finding of adult influenza A [5] [6] [7] [8] [9] . Early in the pandemic, we reviewed complete blood counts in admitted emergency department patients with influenzalike illness for relative lymphopenia (lymphocytes р21% of white blood cells) [5, 6] . It quickly became apparent that the demand for testing exceeded the emergency department's ability. We reasoned that, like adult human influenza A, relative lymphopenia might be a marker for H1N1 and thus could also be used to prioritize H1N1 PCR testing if the emergency department's ability was exceeded.
Of the 856 patients admitted to the emergency department with influenza-like illness for rapid influenza testing in April and May, 229 had positive results for influenza A and 13 had positive results for influenza B (Table 1) . Because the rapid influenza test for influenza A may be associated with false negative results but not false positive results, we believe 25 adults with positive test results for influenza A with complete blood counts had H1N1.
Complete blood counts were obtained in all 25 adults and 16 children who tested positive for influenza A with probable H1N1. Relative lymphopenia (р21% of white blood cells) was present in 23 of these 25 adults (it was not evaluated in 2). These 23 adults had no other disorders associated with relative lymphopenia [5] . Thrombocytopenia (р160 ϫ 10 3 platelets/ mm ) was not present in any of the 25 adults (Table 2) . Atypical lymphocytes were present in 3 of 16 children but no adults with influenza A and in no patients with influenza B (Table 3) .
Like human seasonal influenza A, relative lymphopenia appears to be a laboratory marker of H1N1. In adults with positive test results for H1N1, relative lymphopenia with or without thrombocytopenia was common, but leukopenia was not present. Our first adult patient with severe human seasonal influenza A, admitted to the hospital and requiring mechanical ventilation, had profound and prolonged relative lymphopenia with thrombocytopenia but not leukopenia.
In children with influenza A, relative lymphopenia was uncommon (in 3 of 16 children). In adults who test positive for influenza A by the rapid influenza test, relative lymphopenia appears to be a marker to identify those likely to have H1N1 and thus to merit specific RT-PCR testing. To the Editor-There is a problem in extrapolating the results of Laraque et al [1] into the Centers for Disease Control and Prevention (CDC) recommendation regarding nucleic acid amplification (NAA) testing, that "NAA testing should be performed from at least one respiratory specimen from each patient with signs and symptoms of pulmonary TB from whom a diagnosis of TB is being considered but has not yet been established" [2, p. 7] . The area of dispute does not involve those cases in which the acidfast bacilli (AFB) smear result is positive but those cases in which the result is negative. The value of using NAA testing in these cases will depend on the true incidence of tuberculosis-positive cultures in the population being tested. Using the approximate numbers given in the article by Laraque et al [1] , ∼30% of samples submitted for AFB testing had positive culture results. Even in this highprevalence scenario, 70% of the samples submitted will have negative culture results. Of the culture positive samples, ∼50% (15 of the original 100 samples) had positive smear results. This would result in ∼15 culture-positive samples, of 100 samples received, that would also be tested by NAA. An 80% sensitivity of NAA would lead to 12 culture-positive cases being detected among 85 samples with negative smear results. In most hospital laboratories, the rate of cultures positive for tuberculosis is much lower than this. In my laboratory, only 6 (2%) of 299 specimens submitted for tuberculosis culture had positive results within the past year.
The use of NAA testing for all specimens submitted for culture would not lead to an earlier diagnosis in a significant number of cases, but it would lead to a substantial increase in cost. In the "real world," samples are received for testing from patients with a wide range of tuberculosis probability. It would be unrealistic to expect the laboratory alone to assess which specimen should be assigned to NAA testing in the event of a negative AFB smear result. In locations in which the rate of cultures positive for tuberculosis is low, it might be more cost effective to restrict NAA testing to cases with positive smear results and to those cases with negative smear results in which an expert clinician considers there to be a high likelihood of tuberculosis. Although the CDC recommendations suggest restricting NAA testing to this targeted population, others may decide to use NAA testing on all samples received for tuberculosis testing.
